Live
- Supreme Court Limits Definition of "Material Resources of the Community"
- MP CM approves reservation for women upto 35 pc
- JMM-Cong-RJD plotted to alter Jharkhand's demography via land jihad, love jihad: Yogi Adityanath
- Country’s first museum on women achievers to open in Delhi next year: L-G
- India's Wedding Season Set to Generate Rs 6 Lakh Crore in Business, Marking 41% Growth
- Kharge campaigns in Jharkhand, replies to BJP’s ‘batenge toh katenge’ slogan
- Addressing shortage of qualified professionals in Indian healthcare crucial: Report
- Career opportunities in sustainable farming
- India Game Developer Conference 2024 to be held from November 13-15
- Former Rajasthan Minister Mahesh Joshi And 22 Others Face Allegations In ₹1000-Crore Jal Jeevan Mission Scam
Centre asks States to ensure drugs at affordable prices
New Delhi: The central government on Tuesday asked National Pharmaceutical Pricing Authority (NPPA), Drugs Controller General of India (DCGI) and...
New Delhi: The central government on Tuesday asked National Pharmaceutical Pricing Authority (NPPA), Drugs Controller General of India (DCGI) and State governments to ensure adequate supply of APIs and formulations at affordable prices in the market.
It also issued instructions to NPPA, DCGI and state governments to prevent black marketing, illegal hoarding, artificial
shortages of active pharmaceutical ingredients (APIs) and formulations in the country.
NPPA has also written to chief secretaries of states with copies to principal secretaries (health) and state drug controllers urging them to closely monitor the production and availability of APIs and formulations to prevent the black marketing and hoarding in their states or UTs, the Department of Pharmaceuticals (DoP) said in a statement.
